Lupus Science & Medicine
ACR classification criteria in childhood-onset systemic lupus erythematosus. Adv Rheumatol 2019;59:20. 23 Aringer M, Costenbader K, Daikh D, et al . 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol 2019;71:1400–12. 24 Statistics Canada. Ethnic origin reference guide, census of population, 2016 .2017:5. 25 Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29:288–91. 26 Gladman D, Ginzler E, Goldsmith C, et al . The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363–9. 27 Ibañez D, Urowitz MB, Gladman DD. Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus. J Rheumatol 2003;30:1977–82. 28 Delis DC, Kaplan E, Kramer JH. Delis-Kaplan Executive Function System (D-KEFS) Examiner’s Manual . San Antonio, TX: The Psychological Corporation, 2001. 29 Conners Continuous Performance Test 3rd Edition (Conners CPT 3) . North Tonawanda, NY: Multi-Health Systems, 2014. 30 Wechsler D. Wechsler Adult Intelligence Scale–Fourth Edition (WAIS- IV) . San Antonio, TX: The Psychological Corporation, 2008. 31 Wechsler D. WISC-V: Technical and Interpretive Manual . NCS Pearson Incorporated, 2014. 32 Fan Z, Hai W, Xianyi Z, et al . n.d. Advancements in understanding neuropsychiatric lupus: deciphering immune heterogeneity with single-cell resolution. Front Med 12:1732805. 33 Crews F, He J, Hodge C. Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol Biochem Behav 2007;86:189–99. 34 Hirohata S, Kikuchi H. Role of serum IL-6 in neuropsychiatric systemic lupus erythematosus. ACR Open Rheumatol 2021;3:42–9. 35 Duerksen J, Lopez RCT, Tappia PS, et al . Efficacy of biomarkers and imaging techniques for the diagnosis of traumatic brain injury: challenges and opportunities. Mol Cell Biochem 2025;480:2797–814. 36 Willard C, Puglisi L, Ravi D, et al . Combined magnetic resonance imaging and serum analysis reveals distinct multiple sclerosis types. Brain (Bacau ) 2025;148:4578–91. 37 Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000;57:925–35.
9 Aw E, Zhang Y, Carroll M. Microglial responses to peripheral type 1 interferon. J Neuroinflammation 2020;17:340. 10 Wang J, Yang C, Zhao Q, et al . Microglia activation induced by serum of SLE patients. J Neuroimmunol 2017;310:135–42. 11 Liang MH, Corzillius M, Bae SC, et al . The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis & Rheumatism 1999;42:599–608. 12 Frittoli RB, Pereira DR, Lapa AT, et al . Axonal dysfunction is associated with interferon- γ levels in childhood-onset systemic lupus erythematosus: a multivoxel magnetic resonance spectroscopy study. Rheumatology (Oxford ) 2022;61:1529–37. 13 Zetterberg H, Blennow K. Fluid biomarkers for mild traumatic brain injury and related conditions. Nat Rev Neurol 2016;12:563–74. 14 Koní č ková D, Menšíková K, Tu č ková L, et al . Biomarkers of neurodegenerative diseases: biology, taxonomy, clinical relevance, and current research status. Biomedicines 2022;10:1760. 15 Restuccia G, Susinna C, Marafioti G, et al . Serum and cerebrospinal fluid biomarkers as predictors of cognitive impairment in multiple sclerosis: a systematic review of longitudinal studies. J Neurol 2025;273:36. 16 Abdelhak A, Foschi M, Abu-Rumeileh S, et al . Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol 2022;18:158–72. 17 Engel S, Boedecker S, Marczynski P, et al . Association of serum neurofilament light chain levels and neuropsychiatric manifestations in systemic lupus erythematosus. Ther Adv Neurol Disord 2021;14:17562864211051497. 18 Kammeyer R, Chapman K, Furniss A, et al . Blood-based biomarkers of neuronal and glial injury in active major neuropsychiatric systemic lupus erythematosus. Lupus (Los Angel ) 2024;33:1116–29. 19 Zervides KA, Janelidze S, Nystedt J, et al . Plasma and cerebrospinal fluid neurofilament light concentrations reflect neuronal damage in systemic lupus Erythematosus. BMC Neurol 2022;22:467. 20 Zervides KA, Grenmyr E, Janelidze S, et al . The impact of disease activity and interferon- α on the nervous system in systemic lupus erythematosus. Arthritis Res Ther 2025;27:60. 21 Balajková V, Prokopcová A, Elisak M, et al . Elevated serum neurofilament light chain levels in patients with neuropsychiatric systemic lupus erythematosus: a cross-sectional study. Lupus Sci Med 2025;12:e001309. 22 Rodrigues Fonseca A, Felix Rodrigues MC, Sztajnbok FR, et al . Comparison among ACR1997, SLICC and the new EULAR/
10
Mwizerwa O, et al . Lupus Science & Medicine 2026; 13 :e001922. doi:10.1136/lupus-2025-001922
Powered by FlippingBook